Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Interest Coverage Ratio (2009 - 2026)

Charles River Laboratories International (CRL) posted Interest Coverage Ratio of 3.95 for Q2 2026, down 11.87% on a QoQ basis from 4.48 in Q1 2026, and up 18.26% year-over-year from 3.34 in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Interest Coverage Ratio (2009 - 2026) Analysis & Trends

Charles River Laboratories International has reported Interest Coverage Ratio for 18 years, with the latest figure at 3.95 in Q2 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 18.26% year-over-year to 3.95 in Q2 2026; TTM through Jun 2026 was 0.85, a 20.72% decrease from a year earlier, with the FY2025 full-year figure at 0.24, down 86.94% from the prior year.
  • Interest Coverage Ratio was 3.95 for Q2 2026 at Charles River Laboratories International, down from 4.48 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 50.61 in Q2 2022, with the low at 11.92 in Q4 2025.
  • Average Interest Coverage Ratio over 5 years is 6.47, with a median of 4.49 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio jumped 495.7% in 2022, then tumbled 249.88% in 2024.
  • Over 5 years, Interest Coverage Ratio stood at 4.71 in 2022, then declined by 15.87% to 3.96 in 2023, then slumped by 249.88% to 5.94 in 2024, then sank by 100.73% to 11.92 in 2025, then jumped by 133.15% to 3.95 in 2026.
  • The last three Interest Coverage Ratio figures came in at 3.95 (Q2 2026), 4.48 (Q1 2026), and 11.92 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 2.57
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 2.83
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 3.95
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn -
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -
10 VivoSim Labs 1.37 Mn 1.37 Mn - -689.75
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 3.95
Mar 28, 2026 4.48
Dec 27, 2025 -11.92
Sep 27, 2025 5.27
Jun 28, 2025 3.34
Mar 29, 2025 2.68
Dec 28, 2024 -5.94
Sep 28, 2024 3.88
Jun 29, 2024 4.63
Mar 30, 2024 3.60
Dec 30, 2023 3.96
Sep 30, 2023 4.49
Jul 1, 2023 4.71
Apr 1, 2023 4.88
Dec 31, 2022 4.71
Sep 24, 2022 13.27
Jun 25, 2022 50.61
Mar 26, 2022 15.77
Dec 25, 2021 14.97
Sep 25, 2021 9.47